trial · primary record
Albumin
Acute Ischemic Stroke
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1192 |
| Primary completion | 2027-12-01 |
| Primary endpoint | Proportion of patients with mRS 0-2 or return to baseline mRS (if the baseline premorbid mRS =3-4) at 90 days. |
| Registry ID | NCT07263308 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:53.255Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07263308
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.